Triple Negative Breast Neoplasms
Conditions
Interventions
This is a double-blind randomized controlled clinical study. A total of 128 people who meet the eligibility criteria will be probabilistically allocated to one or the other intervention group using a
G07.203.300.456
Sponsors
Faculdade de Nutrição da Universidade Federal de Goiás
Hospital de Câncer Araújo Jorge
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients undergoing oncological follow-up for up to 5 years after the last treatment performed, who were diagnosed with triple-negative breast cancer in Stages I to III; attended at the Mastology and Gynecology outpatient clinic of the hospital; age = 18 years; women; is not receiving a nutritional supplement; be able to sign the TCLE; who is on an exclusive oral diet
Exclusion criteria
Exclusion criteria: Participants using anti-inflammatory drugs; patients diagnosed with Diabetes Melittus type I and II; post-treatment patients with other types of cancer; cognitive and/or walking disability; with a closed diagnosis of metastasis; feeding that is not exclusively oral; absorptive dysfunctions (Crohn's, ulcerative colitis, short bowel syndrome); autoimmune diseases; liver diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Juçara is expected to improve the lipid profile and reduce body fat. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find in the pulp of juçara a high content of anthocyanin, phenolic compounds and antioxidant capacity, good acceptance and satiety before the consumption of the pulp. In the cross-sectional study, we hypothesized to find a high cardiovascular risk in post-treatment triple-negative breast cancer patients. | — |
Countries
Brazil
Contacts
Public ContactJéssika Siqueira
Faculdade de Nutrição da Universidade Federal de Goiás
Outcome results
None listed